Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?

SIMPLE SUMMARY: T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy arising from the aberrant proliferation of immature T-cell progenitors. Despite improved insights in genetic and biological characteristics of T-ALL, clinical therapy has remained largely similar. Recent studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ziting, Yang, Kun, Zhang, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688677/
https://www.ncbi.nlm.nih.gov/pubmed/36428753
http://dx.doi.org/10.3390/cancers14225655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688677/
https://www.ncbi.nlm.nih.gov/pubmed/36428753
http://dx.doi.org/10.3390/cancers14225655

Ejemplares similares